Last week we told you about Dr. Bart Barlogie leaving the University of Arkansas for Medical Sciences for Mount Sinai Hospital in New York.
We weren’t able to reach him in time for last week’s Whispers, but we caught up with him recently though email.
He said that at the myeloma program at Mount Sinai he’ll be doing clinical care and research and “dedicating myself to finding answers to high-risk myeloma,” just as he did at UAMS.
It was difficult for him to leave UAMS, he said, where he had been for more than a quarter of a century.
Barlogie stepped down as director of the institute in 2014 and helped recruit his successor, Dr. Gareth Morgan, a cancer researcher from London.
“Having recruited Gareth Morgan as my successor at the Myeloma Institute, we came to realize that it would be better for me to move on,” Barlogie said in the email.
He left UAMS at the end of August.
Barlogie said that at Mount Sinai he joined “an established” myeloma program headed by his longtime friend and colleague, Dr. Sundar Jagannath.
“Sundar followed me from MD Anderson in Houston in 1989, and we developed what became the Myeloma Institute at UAMS together,” Barlogie said. Now “quite a few” of his UAMS patients are following him to New York, he said.
